Medical Oncology

, Volume 28, Issue 2, pp 409–415 | Cite as

Weight gain after adjuvant chemotherapy in patients with early breast cancer in Istanbul Turkey

  • Gul Basaran
  • Nazım Serdar Turhal
  • Devrim Cabuk
  • Nevin Yurt
  • Gul Yurtseven
  • Mahmut Gumus
  • Mehmet Teomete
  • Faysal Dane
  • Perran Fulden Yumuk
Original Paper


Weight gain is a well-known and unwanted complication of adjuvant chemotherapy in breast cancer. We observed that the female Turkish cancer patients frequently gain weight with adjuvant treatment of breast cancer and planned to examine the magnitude of this problem in early breast cancer patients treated at our hospital. A total of 176 early breast cancer patients who received their adjuvant systemic therapy in Marmara University Hospital between 2003 and 2007 are included in the study. We recorded their weight before and after chemotherapy and also a year after chemotherapy to find out whether the change with weight is transitory. We have also recorded demographic information, including the educational level, menopausal status, the type of chemotherapy or hormonal treatment administered stage of disease, marital status, occupation and the underlying diseases to analyze the relationship between change in weight and these parameters. Median age of patients was 53 and 72% of patients were postmenopausal. Educational level was equally distributed for primary education (27%), high school (40%), and university (33%). The majority of the patients (76%) was married, had two children (69%) and was housewife (60%). Family history of any cancer was high (32%). Most of the patients had stage II cancer (56%), received anthracyclines+/− taxane based chemotherapy (98%) and had no underlying disease (68%). The majority also did not smoke (73%) or drink alcohol (93%). A total of 67% and 72% patients gained weight upon completion and one year after completion of chemotherapy. Mean weight before the chemotherapy, upon completion of chemotherapy and one year after completion of chemotherapy were 68.9 kg, 70.6 kg (P = 0.000) and 71.9 kg (P = 0.000) respectively. Mean body mass index was 27.1 at baseline, 27.8 upon completion of chemotherapy (P = 0.000) and 28.3 one year after completion of chemotherapy (P = 0.000). Age, menopausal status, multiparity and presence of comorbid diseases had statistically significant impact on weight gain following adjuvant therapy in breast cancer patients (P = 0.000, P = 0.008, P = 0.015 and P = 0.017 respectively). This study shows that Turkish women with early breast cancer gain weight after adjuvant systemic therapy, in line with European and American counterparts. This increase in weight is maintained at least one year after adjuvant therapy. Given the adverse consequences of weight gain in terms of both breast cancer prognosis and general health, it is necessary to inform patients about this change and to develop strategies for weight maintenance during and after systemic therapy.


Chemotherapy Breast cancer Adjuvant treatment Weight gain 


  1. 1.
    Tao MH, Shu XO, Ruan ZX, Gao YT, Zheng W. Association of overweight with breast cancer survival. Am J Epidemiol. 2006;163(2):101–7.PubMedCrossRefGoogle Scholar
  2. 2.
    Whiteman MK, et al. Body mass and mortality after breast cancer diagnosis. Cancer Epidemiol Biomarkers Prev. 2005;14(8):2009–14.PubMedCrossRefGoogle Scholar
  3. 3.
    Goodwin PJ, Boyd NF. Body size and breast cancer prognosis: a critical review of the evidence. Breast Cancer Res Treat. 1990;16(3):205–14.PubMedCrossRefGoogle Scholar
  4. 4.
    Vatten LJ, Foss OP, Kvinnsland S. Overall survival of breast cancer patients in relation to preclinically determined total serum cholesterol, body mass index, height and cigarette smoking: a population-based study. Eur J Cancer. 1991;27(5):641–6.PubMedCrossRefGoogle Scholar
  5. 5.
    Senie RT, Rosen PP, Rhodes P, Lesser ML, Kinne DW. Obesity at diagnosis of breast carcinoma influences duration of disease-free survival. Ann Intern Med. 1992;116(1):26–32.PubMedGoogle Scholar
  6. 6.
    Bastarrachea J, Hortobagyi GN, Smith TL, Kau SW, Buzdar AU. Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer. Ann Intern Med. 1994;120(1):18–25.PubMedGoogle Scholar
  7. 7.
    Dixon JK, Moritz DA, Baker FL. Breast cancer and weight gain: an unexpected finding. Oncol Nurs Forum. 1978;5(3):5–7.PubMedGoogle Scholar
  8. 8.
    Camoriano JK, et al. Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J Clin Oncol. 1990;8(8):1327–34.PubMedGoogle Scholar
  9. 9.
    Chlebowski RT, et al. Long-term survival following relapse after 5-FU but not CMF adjuvant breast cancer therapy. Breast Cancer Res Treat. 1986;7(1):23–30.PubMedCrossRefGoogle Scholar
  10. 10.
    Levine EG, Raczynski JM, Carpenter JT. Weight gain with breast cancer adjuvant treatment. Cancer. 1991;67(7):1954–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Boyd NF, et al. Body weight and prognosis in breast cancer. J Natl Cancer Inst. 1981;67(4):785–9.PubMedGoogle Scholar
  12. 12.
    Goodwin PJ, Panzarella T, Boyd NF. Weight gain in women with localized breast cancer–a descriptive study. Breast Cancer Res Treat. 1988;11(1):59–66.PubMedCrossRefGoogle Scholar
  13. 13.
    Makari-Judson G, Judson CH, Mertens WC. Longitudinal patterns of weight gain after breast cancer diagnosis: observations beyond the first year. Breast J. 2007;13(3):258–65.PubMedCrossRefGoogle Scholar
  14. 14.
    Loi S, et al. Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev. 2005;14(7):1686–91.PubMedCrossRefGoogle Scholar
  15. 15.
    Caan BJ, et al. Post-diagnosis weight gain and breast cancer recurrence in women with early stage breast cancer. Breast Cancer Res Treat. 2006;99(1):47–57.PubMedCrossRefGoogle Scholar
  16. 16.
    Kroenke CH, Chen WY, Rosner B, Holmes MD. Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol. 2005;23(7):1370–8.PubMedCrossRefGoogle Scholar
  17. 17.
    Demark-Wahnefried W, et al. Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol. 2001;19(9):2381–9.PubMedGoogle Scholar
  18. 18.
    Demark-Wahnefried W, Rimer BK, Winer EP. Weight gain in women diagnosed with breast cancer. J Am Diet Assoc. 1997;97(5):519–26.PubMedCrossRefGoogle Scholar
  19. 19.
    Rock CL, et al. Factors associated with weight gain in women after diagnosis of breast cancer. Women’s Healthy Eating and Living Study Group. J Am Diet Assoc. 1999;99(10):1212–21.PubMedCrossRefGoogle Scholar
  20. 20.
    Goodwin PJ, et al. Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis. J Clin Oncol. 1999;17(1):120–9.PubMedGoogle Scholar
  21. 21.
    Irwin ML, et al. Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors. J Clin Oncol. 2005;23(4):774–82.PubMedCrossRefGoogle Scholar
  22. 22.
    Campbell KL, et al. Resting energy expenditure and body mass changes in women during adjuvant chemotherapy for breast cancer. Cancer Nurs. 2007;30(2):95–100.PubMedCrossRefGoogle Scholar
  23. 23.
    Saquib N, et al. Weight gain and recovery of pre-cancer weight after breast cancer treatments: evidence from the women’s healthy eating and living (WHEL) study. Breast Cancer Res Treat. 2007;105(2):177–86.PubMedCrossRefGoogle Scholar
  24. 24.
    Han HS, et al. Weight changes after adjuvant treatment in Korean women with early breast cancer. Breast Cancer Res Treat. 2009;114(1):147–53.PubMedCrossRefGoogle Scholar
  25. 25.
    Ono T, Guthold R, Strong K. Who Glabal Comparable Estimates, 2005 ( IBRef: 199999).
  26. 26.
    Demark-Wahnefried W, Winer EP, Rimer BK. Why women gain weight with adjuvant chemotherapy for breast cancer. J Clin Oncol. 1993;11(7):1418–29.PubMedGoogle Scholar
  27. 27.
    Heideman WH, Russell NS, Gundy C, Rookus MA, Voskuil DW. The frequency, magnitude and timing of post-diagnosis body weight gain in Dutch breast cancer survivors. Eur J Cancer. 2009;45(1):119–26.PubMedCrossRefGoogle Scholar
  28. 28.
    Aslani A, Smith RC, Allen BJ, Pavlakis N, Levi JA. Changes in body composition during breast cancer chemotherapy with the CMF-regimen. Breast Cancer Res Treat. 1999;57(3):285–90.PubMedCrossRefGoogle Scholar
  29. 29.
    Demark-Wahnefried W, et al. Reduced rates of metabolism and decreased physical activity in breast cancer patients receiving adjuvant chemotherapy. Am J Clin Nutr. 1997;65(5):1495–501.PubMedGoogle Scholar
  30. 30.
    Grindel CG, Cahill CA, Walker M. Food intake of women with breast cancer during their first six month of chemotherapy. Oncol Nurs Forum. 1989;16(3):401–7.PubMedGoogle Scholar
  31. 31.
    Knobf MK, Mullen JC, Xistris D, Moritz DA. Weight gain in women with breast cancer receiving adjuvant chemotherapy. Oncol Nurs Forum. 1983;10(2):28–33.PubMedGoogle Scholar
  32. 32.
    McInnes JA, Knobf MT. Weight gain and quality of life in women treated with adjuvant chemotherapy for early-stage breast cancer. Oncol Nurs Forum. 2001;28(4):675–84.PubMedGoogle Scholar
  33. 33.
    Day R, et al. Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Clin Oncol. 1999;17(9):2659–69.PubMedGoogle Scholar
  34. 34.
    Kumar NB, et al. Weight gain associated with adjuvant tamoxifen therapy in stage I and II breast cancer: fact or artifact? Breast Cancer Res Treat. 1997;44(2):135–43.PubMedCrossRefGoogle Scholar
  35. 35.
    Hoskin PJ, Ashley S, Yarnold JR. Weight gain after primary surgery for breast cancer-effect of tamoxifen. Breast Cancer Res Treat. 1992;22(2):129–32.PubMedCrossRefGoogle Scholar
  36. 36.
    Boyd NF. Nutrition and breast cancer. J Natl Cancer Inst. 1993;85(1):6–7.PubMedCrossRefGoogle Scholar
  37. 37.
    Irwin ML, et al. Physical activity levels before and after a diagnosis of breast carcinoma: the health, eating, activity, and lifestyle (HEAL) study. Cancer. 2003;97(7):1746–57.PubMedCrossRefGoogle Scholar
  38. 38.
    Schwartz AL. Exercise and weight gain in breast cancer patients receiving chemotherapy. Cancer Pract. 2000;8(5):231–7.PubMedCrossRefGoogle Scholar
  39. 39.
    McTiernan A. Obesity and cancer: the risks, science, and potential management strategies. Oncology (Williston Park). 2005;19(7):871–81.Google Scholar
  40. 40.
    Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4(8):579–91.PubMedCrossRefGoogle Scholar
  41. 41.
    Eliassen AH, Colditz GA, Rosner B, Willett WC, Hankinson SE. Adult weight change and risk of postmenopausal breast cancer. JAMA. 2006;296(2):193–201.PubMedCrossRefGoogle Scholar
  42. 42.
    Cohen SS, et al. Parity and breastfeeding in relation to obesity among black and white women in the southern community cohort study. J Womens Health (Larchmt). 2009;18(9):1323–32.CrossRefGoogle Scholar
  43. 43.
    Iseri A, Aslan N. Obesity in adults in Turkey, age and regional effects 2008. ( IBRef: 102944).

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Gul Basaran
    • 1
  • Nazım Serdar Turhal
    • 1
  • Devrim Cabuk
    • 1
  • Nevin Yurt
    • 1
  • Gul Yurtseven
    • 1
  • Mahmut Gumus
    • 2
  • Mehmet Teomete
    • 1
  • Faysal Dane
    • 1
  • Perran Fulden Yumuk
    • 1
  1. 1.Marmara University HospitalIstanbulTurkey
  2. 2.Kartal Research and Education HospitalIstanbulTurkey

Personalised recommendations